MoneyWorks4Me

Evoq Remedies informs about updates

11 Jun 2024 Evaluate
Evoq Remedies has informed that pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, the Stock Exchange BSE Limited (‘BSE’) has issued In-principle approval letter vide Ref: LOO/PREF/ DA/FIP /405/2024-25 dated 11th June, 2024 for the issue of 1,13,00,000 Equity shares. The In-principle approval letter received from the Stock Exchange, BSE is enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers